I disagree. All it takes is one busy doctor to say that they never received notification that their patient has cancer. You're assuming that patients never get lost to follow-up and clinicians are constantly checking and making sure they get all of their results. In a perfect world, yes. In reality, you need to cover your butt. If your lab is CAP-accredited, I believe that it is a requirement to provide documentation that you relayed information on all new cancer diagnoses, etc.
I think we will have to agree to disagree about calling all new malignancy diagnoses and accept that there are significant differences in practice patterns and expectations of clinicians. The varied opinions on this topic here in our forum appear to be similar to what has been found in published surveys and literature on the topic. The most extensive review I could find is this consensus statement by CAP and ADASP (
Consensus statement on effective communication of urgent diagnoses and significant, unexpected diagnoses in surgical pathology and cytopathology fr... - PubMed - NCBI).
Interestingly, one of the large CAP surveys (
Significant and unexpected, and critical diagnoses in surgical pathology: a College of American Pathologists' survey of 1130 laboratories. - PubMed - NCBI) showed that 48% of departments included "malignancy" in their critical diagnosis policy/list and 36% included "all malignancies." So it would appear that you are actually in the minority based on that data. There has also been a push to try and separate "urgent/critical" results from "significant, unexpected" diagnoses, which further complicates the discussion.
I looked it up and, as far as I can tell, the only item in the AP CAP checklist relating to conveyance of diagnoses is this one:
ANP.12175 Significant/Unexpected Findings Phase II
There is a policy regarding the communication and recording of significant and unexpected surgical pathology findings.
NOTE: Certain surgical pathology diagnoses may be considered significant and unexpected. Such diagnoses may include: malignancy in an uncommon location or specimen type (e.g. hernia sac, intervertebral disk material, tonsil, etc.), or change of a frozen section diagnosis after review of permanent sections. There should be a reasonable effort to ensure that such diagnoses are received by the clinician, by means of telephone, pager or other system of notification. There must be records of the date of communication of these diagnoses. The pathology department may designate certain surgical pathology diagnoses for prompt communication to the clinician. Such diagnoses may include, for example, neoplasms causing paralysis, or fat in an endometrial curettage. Diagnoses to be defined as “significant and unexpected,” and those for prompt communication should be determined by the pathology department, in cooperation with local clinical medical staff. Records of communication of these diagnoses may be included in the pathology report, or in other laboratory records.
I would not interpret that this checklist item requires direct communication for "all new cancer diagnoses." I completely agree with you that documentation of communications with clinicians is essential.
I also agree that ensuring that the referring/ordering provider does actually get the results of any testing they have ordered is important and it would be optimal for patient care to prevent anyone from falling through the cracks. However, one has to balance the reduced risk to patients with efficient use of limited resources. At some point, it becomes infeasible for pathologists to personally confirm that the ordering provider has received and understood the results of every case.
In my practice, it would not be practical to call on all new malignancies. For reference, January is the month in which the surgical case load per pathologist is lowest in our group (because the fewest vacation days are taken). I did a quick lookup of my cases from last week. There were 22 new malignancy diagnoses - about 4-5 per day. When I try to reach the relevant physician (and, no, I don't ever try to call the radiologist), I get their office receptionist, who inevitably tells me they are rouding/with a patient, in the OR or off that day and I have to leave a detailed message including the patient's name, DOB, etc. They usually do (eventually) call me back, although we can end up in a horrible game of phone tag if they happen to call while I am doing a frozen, at a meeting or otherwise not in my office. I would say on average it takes me about 10-15 minutes total to speak to a clinician on a straightforward case and document it - that would be an additional 40-75 minutes per day during the slowest month of the year. Not a feasible or efficient use of pathologist resources in my opinion.
On a side note, I have to ask the purpose of having a useful discussion regarding ancillary breast biomarkers on a breast cancer case or molecular/FISH results on a lung cancer case. In my mind, it's enough to let the oncologist or primary doctor know that the patient has cancer (with a specific diagnosis that has been fully worked up with IHC if necessary). The ancillary studies don't change the fact the patient has a certain cancer. Those studies are to provide more info about prognostication and for therapeutics. If something like a heme case comes up and I render a diagnosis of "diffuse large B-cell lymphoma with high grade features"... I will let the oncologist know ASAP so they can begin treatment. Then, once I get my FISH studies back, I can call again to relay any pertinent info that may change my original diagnosis. So in that regard, I may call a clinician at least twice on the same cancer case. Is this overkill?
Yes, it is useful at some level to know the patient "officially" has "cancer." The sometimes arduous process of setting up appointments with oncology, surgery, radiation, etc., can then be started. However, at least in our neck of the woods, I don't believe that a call to a clinician at 9:00 am to tell them that a biopsy is positive vs. them getting the final report at 4:00-5:00 pm that day (or the next morning) would result in patients getting specialty appointments significantly earlier. I already mentioned that very ill inpatients/new leukemias/lymphomas who actually would be in a position to get urgent/same day treatment are an exception and, in select cases in which the physician does want a phone call, they just write that on the requisition and we call them.
I think that more often than not, most clinicians would be more pissed off if they didn't hear from their pathologist regarding a new malignancy. You have to establish a relationship with your clients/clinicians. Mine are more than OK with me calling them personally to relay this type of information.
Step through the paraffin curtain and talk to your doctor colleagues and let them know you exist.
If you have the time to call your docs and they are used to getting that many calls, great. Local practice here is not to call on every single new malignancy, but that does not imply that I don't have an established relationship with the physicians here - they definitely know I exist. I think it is a bit harsh and unwarranted to jump to the conclusion that I am not an effective communicator or not providing "great customer service" because there is some local/regional variation in practice patterns in regards to one particular gray area in critical/unexpected diagnosis reporting.